Inhibition of δ-aminolevulinate dehydratase is not closely related to the development of hyperglycemia in alloxan-induced diabetic mice

Experimental and Toxicologic Pathology

Volumn 63, Issue 5, 2011, Pages 443-451

  Brito, Verônica B ^a,b   da Rocha, João Batista T ^a   Puntel, Gustavo O ^a,c   da Luz, Sônia Cristina A ^a   Barbosa, Nilda B V ^a   de Carvalho, Nelson R ^a   Folmer, Vanderlei ^a,c  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSITY OF LISBON   (Portugal)

^c UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

Author keywords

Alloxan; Diabetes; Hyperglycemia; Mice; Sulfhydryl groups; ALA D

Indexed keywords

ALLOXAN; GLUCOSE; MALONALDEHYDE; PORPHOBILINOGEN SYNTHASE; THIOL DERIVATIVE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME REACTIVATION; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; KIDNEY PARENCHYMA; LIPID PEROXIDATION; LIVER; MALE; MOUSE; NONHUMAN;

ANIMALIA; MUS;

EID: 84984548964     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.03.003     Document Type: Article

References (60)

1. Ammon H.P., Mark M. Thiols and pancreatic beta-cell function: a review. Cell Biochem Funct 1985, 3:157-171.
2. Barbosa N.B., Zeni G., Emanuelli T., Beque M.C., Braga A.L. Effect of organic forms of selenium on delta-aminolevulinate dehydratase from liver, kidney, and brain of adult rats. Toxicol Appl Pharmacol 1998, 149:243-253.
3. Berlin A., Schaller K.H. European standardized method for the determination of δ-aminolevulinic acid dehydratase activity in blood. Z Klin Chem Klin Biochem 1974, 12:389-390.
4. Bhattacharya S.K., Robson J.S., Stewart C.P. The glutathione content of blood and tissues following alloxan and dehydroascorbic acid injections. Biochem J 1956, 62:12-21.
5. Bo S., Ciccone G., Gancia R., Rosato R., Grassi G., Merletti F., Pagano G.F. Mortality within the first 10 years of the disease in type 2 diabetic patients. NMCD 2006, 16:8-12.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976, 72:248-254.
7. Brito V.B., Folmer V., Soares J.C.M., Silveira I.D., Rocha JBT Long-term sucrose and glucose consumption decreases the delta-aminolevulinate dehydratase activity in mice. Nutrition 2007, 23:818-826.
8. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995, 46:23-34.
9. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
10. Bruckmann G., Wertheimer E. Alloxan studies: the action of alloxan homologues and related compounds. J Biol Chem 1947, 168:241-256.
11. Burnham T.K., Fossnaugh R.P. Porphyria, diabetes and their relations. Arch Dermatol 1961, 83:717-722.
12. Caballero F., Gerez E., Pólo C., Mompo O., Vazquez E., Schultz R., Bernabo J., Batlle A. Alteraciones en el camino metabolico del hemo en pacientes diabéticos. Medicina 1995, 55:117-124.
13. Caballero F.A., Gerez E.N., Polo C.F., Vazquez E.S. Batlle AMC. Reducing sugars trigger δ-aminolevulinate dehydratase inactivation: evidence of in vitro aspirin prevention. Gen Pharmacol 1998, 31:441-445.
14. Chaturvedi N. The burden of diabetes and its complications: trends and implications for intervention. Diabetes Res Clin Pract 2007, 76:S3-S12.
15. Day J.F., Thornburg S.R., Baynes J.W. Non-enzymatically glycosylated albumin. J Biol Chem 1997, 254:595-597.
16. Dunn J.S., Sheehan H.L., McLetchie N.G.B. Necrosis of islets of Langerhans produced experimentally. Lancet 1943, 1:484-487.
17. Ellman G.L. Tissue sulphydril groups. Arch Biochem Biophys 1959, 82:70-77.
18. Elsner M., Gurgul-Convey E., Lenzen S. Relation between triketone structure, generation of reactive oxygen species, and selective toxicity of the diabetogenic agent alloxan. ARS 2008, 10:691-699.
19. Elsner M., Gurgul-Convey E., Lenzen S. Relative importance of cellular uptake and reactive oxygen species for the toxicity of alloxan and dialuric acid to insulin-producing cells. Free Radic Biol Med 2006, 41:825-834.
20. Elsner M., Tiedge M., Guldbakke B., Munday R., Lenzen S. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan. Diabetologia 2002, 45:1542-1549.
21. Farina M., Brandão R., de Lara F.S., Pagliosa L.B., Soares F.A., Souza D.O., Rocha JBT Profile of nonprotein thiols, lipid peroxidation and delta-aminolevulinate dehydratase activity in mouse kidney and liver in response to acute exposure to mercuric chloride and sodium selenite. Toxicology 2003, 3:179-187.
22. Farina M., Brandão R., de Lara F.S., Soares F.A.A., Souza D.O., Rocha JBT Mechanisms of the inhibitory effects of selenium and mercury on the activity of δ-aminolevulinate dehydratase from mouse liver, kidney and brain. Toxicol Lett 2003, 139:55-66.
23. Folmer V., Soares J.C.M., Gabriel D., Rocha JBT A high fat diet inhibits delta-aminolevulinate dehydratase and increases lipid peroxidation in mice (mus musculus). J Nutr 2003, 133:2165-2170.
24. Folmer V., Soares J.C.M., Rocha JBT Oxidative stress in mice is dependent on the free glucose content of the diet. Int J Biochem Cell Biol 2002, 34:1279-1285.
25. Fu M.X., Wells-Knecht K.J., Blackledge J.A., Lyons T.J., Thorpe S.R., Baynes JW Glycation glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 1994, 43:676-683.
26. Goerz G., Korda S. Porphyria cutanea tarda and diabetes mellitus. Z Hautkr 1977, 52:1165-1174.
27. Grankvist K., Marklund S.L., Sehlin J., Taljedal I.B. Superoxide dismutase, catalase and scavengers of hydroxyl radical protect against the toxic action of alloxan on pancreatic islets in vitro. Biochem J 1979, 182:17-25.
28. Grossman M.E., Bickers D.R., Poh-Fitzpatrick M.B., Deleo V.A., Harber L.C. Porphyria cutanea tarda: clinical features and laboratory findings in 40 patients. Am J Med 1979, 67:277-286.
29. Halici Z., Bilen H., Albayrak F., Uyanik A., Cetinkaya R., Suleyman H., Keles O.N., Unal B. Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes?. Eur J Pharmacol 2009, 614:146-152.
30. Kiersztan A., Baranska A., Hapka M., Lebiedzinska M., Winiarska K., Dudziak M., Bryla J. Differential action of methylselenocysteine in control and alloxan-diabetic rabbits. Chem Biol Int 2009, 177:161-171.
31. Leech R., Bailey C. Blood alloxan and blood glutathione in rabbits injected with alloxan. J Biol Chem 1945, 157:525-542.
32. Lenzen S., Munday R. Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin. Biochem Pharmacol 1991, 42:1385-1391.
33. Lenzen S., Panten U. Alloxan: history and mechanism of action. Diabetologia 1988, 31:337-342.
34. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008, 51:216-226.
35. Lisi P., Santeusanio F., Lombardi G., Compagnucci P. Carbohydrate metabolism in porphyria cutanea tarda. Dermatologica 1983, 166:287-293.
36. Magnin P.H., Lenczner J.M. Datos de interes clinico en el examen y evolución de enfermos con porfiria cutánea tardia en los ultimos 15 años. Rev Argent Dermatol 1990, 71:45-47.
37. Mir S.J., Darzi M.M. Histopathological abnormalities of prolonged alloxan-induced-diabetes mellitus in rabbits. Int J Exp Pathol 2009, 90:66-73.
38. Mohamed A.K., Bierhaus A., Schiekofer S., Tritschler H., Ziegler R., Nawroth P.P. The role of oxidative stress and NF-κB activation in late diabetic complications. Biofactors 1999, 10:157-167.
39. Munday R. Dialuric acid autoxidation. Effect of transition metals on the reaction rate and on generation of 'active oxygen' species. Biochem Pharmacol 1988, 37:409-413.
40. Nukatsuka M., Sakurai H., Kawada J. Generation of alloxan free radicals in chemical and biological systems: implication in the diabetogenic action of alloxan. Biochem Biophys Res Commun 1989, 165:278-283.
41. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
42. Patterson J.W., Lazarow A., Levey S. Reactions of alloxan and dialuric acid with the sulfhydryl group. J Biol Chem 1949, 177:197-204.
43. Perottoni J., Meotti F.C., Folmer V., Pivetta L., Nogueira C.W., Zeni G., Rocha J.B.T. Ebselen and diphenyl diselenide do not change the inhibitory effect of lead acetate on delta aminolevulinate dehydratase. Environ Toxicol Pharmacol 2005, 19:239-248.
44. Renno W.M., Abdeen S., Alkhalaf M., Asfar S. Effect of green tea on kidney tubules of diabetic rats. Br J Nutr 2008, 100:652-659.
45. Resnikoff S., Pascolini D., Etya'ale D., Kocur I., Pararajasegaram R., Pokharel G.P., Mariotti S.P. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844-851.
46. Rossato J.I., Zeni G., Mello C.F., Rubin M.A., Rocha J.B.T. Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat. Neurosci Lett 2002, 318:137-140.
47. Sajithlal G.B., Chithra P., Chandrakasan G. Advanced glycation end products induce crosslinking of collagen in vitro. BBA-Mol Basis Dis 1998, 1407:215-224.
48. Sassa S. ALAD porphyria. Semin Liver Dis 1998, 18:95-101.
49. Sassa S. Delta-aminolevulinic acid dehydratase assay. Enzyme 1982, 28:133-145.
50. Schwartz J.G. The role of glycohemoglobin and other proteins in diabetes management. Diabetes Rev 1995, 3:269-287.
51. Shemim D. 5-Aminolevulinic acid dehydratase: structure, function, and mechanism. Philos Trans R Soc London, Ser B 1976, 273:109-115.
52. Székely E., Bor M., Tasnád G., Várnai K., Almási A., Blázovic A. Hemorheological status and redox homeostasis of phlebotomised porphyria cutanea tarda patients with diabetes mellitus and in moderate alcohol consumer. Clin Hemorheol Microcirc 2006, 35:387-396.
53. Tiedge M., Krug U., Lenzen S. Modulation of human glucokinase intrinsic activity by SH reagents mirrors post-translational regulation of enzyme activity. Biochim Biophys Acta 1997, 1337:175-190.
54. Tippett P.S., Neet K.E. Interconversions between different sulfhydryl-related kinetic states in glucokinase. Arch Biochem Biophys 1983, 222:285-298.
55. Tsukamoto I., Yoshinaga T., Sano S. The role of zinc with special reference to the essential thiol groups in δ-aminolevulinic acid dehydratase of bovine liver. Biochim Biophys Acta 1979, 570:167-178.
56. Valentini J., Grotto D., Paniz C., Roehrs M., Burg G., Garcia S.C. The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients. Biomed Pharmacother 2008, 62:378-382.
57. Watanabe D., Nakara H., Yamaguchi Y., Akagi K., Hoshiya T., Nagashima Y., Okaniwa A., Yoshikawa H. The pathological features of alloxan diabetes in Beagle dogs. J Toxicol Pathol 2004, 17:187-195.
58. Wijkstrom M., Kirchhof N., Graham M., Ingulli E., Colvin R.B., Christians U, Hering BJ, Schuurman HJ Cyclosporine toxicity in immunosuppressed streptozotocin-diabetic nonhuman primates. Toxicology 2005, 207:117-127.
59. Winterbourn C.C., Munday R. Glutathione-mediated redox cycling of alloxan. Mechanism of SOD inhibition and metal-catalyzed OH° formation. Biochem Pharmacol 1989, 38:271-277.
60. Wolff S.P., Dean R.T. Glucose autoxidation and protein modification: the potential role of 'autoxidative glycosilation' in diabetes. Biochem J 1987, 245:243-250.